The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study
top of page
A framework to support new product introduction in national health systems
This slide deck walks through the initial results of the Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO)...
- Jun 23, 2022
EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG
The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to,...
- May 24, 2022
GAP-f pDTG Implementation Considerations for National Programmes
In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...
- Mar 17, 2022
Adult DRV/r (400/50mg) Clinical Action Memo
Darunavir (DRV) is a best-in-class protease inhibitor (PI) used in combination with other antiretroviral (ARV) drugs for the...
- Mar 17, 2022
CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
- Feb 10, 2022
EGPAF Guidance for Pediatric ARV Quantification and Supply Planning
This guidance from EGPAF is intended for national program managers; technical and clinical advisors; procurement entities; funding...
- Oct 18, 2021
Pediatric DTG Healthcare Worker Resources
CHAI has developed new resources to support healthcare worker decision-making and counselling around pDTG. pDTG HCW Worker Overview Video...
- Aug 16, 2021
Pediatric DTG Introduction: Transition Plan Templates
Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French
- Jul 9, 2021
Community Resources for Pediatric DTG Scale-Up
Optimal and FASTER CAB members, with technical support from CHAI, developed a multi-media package of treatment literacy and advocacy...
- Apr 26, 2021
2021 WHO Optimal Formulary and Limited-Use List for ARVs for Children
This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for...
- Mar 15, 2021
Pediatric DTG Clinical Studies Repository
A CHAI-curated repository of clinical studies in the development and implementation of pediatric DTG.
- May 28, 2020
Optimizing 2L HIV Treatment with DTG-based Regimens
This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...
- Aug 1, 2018
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
bottom of page